LINCOCIN Sterile Solution contains lincomycin hydrochloride which is the monohydrated salt of lincomycin, a substance produced by the growth of a member of the lincolnensis group of Streptomyces …
Intramuscular administration of a single dose of 600 mg of lincomycin produces average peak serum concentrations of 11.6 mcg/mL at 60 minutes and maintains therapeutic concentrations for 17 to 20 …
LINCOCIN Sterile Solution is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for …
This drug is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin.
See BOXED WARNING. Clostridium difficile associated diarrhea – Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including …
General – Review of experience to date suggests that a subgroup of older patients with associated severe illness may tolerate diarrhea less well. When LINCOCIN is indicated in these patients …
The following adverse reactions have been reported with the use of lincomycin. Gastrointestinal disorders – Diarrhea, nausea, vomiting, glossitis, stomatitis, abdominal pain, abdominal …
Serum concentrations of lincomycin are not appreciably affected by hemodialysis and peritoneal dialysis.
If significant diarrhea occurs during therapy, this antibacterial should be discontinued. (see BOXED WARNING) INTRAMUSCULAR – Adults – Serious infections—600 mg (2 mL) intramuscularly every 24 …
LINCOCIN Sterile Solution is available in the following strength and package sizes: 300 mg – 2 mL Vials — NDC 0009-0555-01 – 10 mL Vials — NDC 0009-0555-02 – Each mL of LINCOCIN Sterile Solution …
In vivo experimental animal studies demonstrated the effectiveness of LINCOCIN preparations (lincomycin) in protecting animals infected with Streptococcus viridans,β-hemolytic Streptococcus …
Physically compatible for 24 hours at room temperature unless otherwise indicated. Infusion Solutions – 5% Dextrose Injection – 10% Dextrose Injection – 5% Dextrose and 0.9% Sodium Chloride …
Rx only – This product’s label may have been updated. For current full prescribing information, please visit www.pfizer.com – LAB-0138-11.0 – Revised November 2018
Pfizer – NDC 0009-0555-01 – Lincocin® lincomycin – injection, USP – 300 mg/mL – 1-2 mL
Pfizer – NDC 0009-0555-01 – Lincocin® lincomycin – injection, USP – 300 mg/mL* For intramuscular – or intravenous use – 1-2 mL Vial – Rx only